Hepatitis C 
The MD Magazine Hepatitis C condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Sponsored

Genetic Investigation of Lymphotropism in Hepatitis C
Researchers address the controversial topic of B-cell infection by hepatitis C.
Glecaprevir/pibrentasvir had a 99% SVR rate in a Japanese population.
The US Department of Veteran Affairs is finding success with modern DAAs.
3D treatment helped patients to attain SVR in less than 12 weeks.
Even after eradicating hepatitis C with direct-acting antivirals, high frequency of Tregs could pose complications.
Merck just got $2.54 billion richer with the ruling of a federal jury.
A trip to the beauty salon could result in exposure to dangerous blood-borne viruses.
An investigational regimen of glecaprevir and pibrentasvir has proven to perform well in patients with hepatitis C genotypes 1 to 6 without cirrhosis.
Elbasvir/grazoprevir (Zepatier) and sofosbuvir (Sovaldi) are used to treat hepatitis C around the world, but is one better than the other?

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$